Cargando…

Soluble Interleukin‐6 Receptor Is Released from Receptor‐bearing Cell Lines in vitro

Soluble interleukin‐6 receptor (sIL‐6R) was found to be spontaneously released from human myeloma cell line U266 cells into culture supernatant, and was quantitatively measured with a fluorescence sandwich enzyme‐linked immunosorbent assay employing antibodies specific to IL‐6R. The supernatant IL‐6...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakajima, Toshiharu, Yamamoto, Shinji, Cheng, Ming, Yasukawa, Kiyoshi, Hirano, Toshio, Kishimoto, Tadamitsu, Tokunaga, Tohru, Honda, Mitsuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1992
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918830/ https://www.ncbi.nlm.nih.gov/pubmed/1506271 http://dx.doi.org/10.1111/j.1349-7006.1992.tb00117.x

Ejemplares similares

The in vivo Anti‐tumor Effect of Human Recombinant Interleukin‐6
por: Kitahara, Misa, et al.
Publicado: (1990)

Targeting Interleukin-6: All the Way to Treat Autoimmune and Inflammatory Diseases
por: Tanaka, Toshio, et al.
Publicado: (2012)

Tocilizumab, a humanized anti-interleukin-6 receptor antibody, for treatment of rheumatoid arthritis
por: Mihara, Masahiko, et al.
Publicado: (2011)

346 Clinical Effects of Tocilizumab, a Humanized Anti-interleukin-6 Receptor Antibody, on Patients with Autoimmune and Allergic Diseases
por: Tanaka, Toshio, et al.
Publicado: (2012)

Interleukin-6: discovery of a pleiotropic cytokine
por: Kishimoto, Tadamitsu
Publicado: (2006)

Interplay between interleukin-6 signaling and the vascular endothelium in cytokine storms
por: Kang, Sujin, et al.
Publicado: (2021)

Soluble interleukin-2 receptors in ulcerative colitis
por: Nielsen, O. H., et al.
Publicado: (1993)

Historical overview of the interleukin-6 family cytokine
por: Kang, Sujin, et al.
Publicado: (2020)

Soluble interleukin-18 receptor complex is a novel biomarker in rheumatoid arthritis
por: Takei, Satoko, et al.
Publicado: (2011)

Correction: Historical overview of the interleukin-6 family cytokine
por: Kang, Sujin, et al.
Publicado: (2020)

COVID-19: A New Virus, but a Familiar Receptor and Cytokine Release Syndrome
por: Hirano, Toshio, et al.
Publicado: (2020)

Elevation of soluble interleukin-2 receptor levels in nasal allergy
por: Hisamatsu, K., et al.
Publicado: (1995)

Soluble interleukin-2 receptors in the serum of patients with Hodgkin's disease.
por: Pizzolo, G., et al.
Publicado: (1987)

Purification and characterization of a novel soluble receptor for interleukin 1
Publicado: (1991)

Serum Levels of Soluble Interleukin-2 Receptor in Pulmonary Tuberculosis
por: Choi, Soo Jeon, et al.
Publicado: (1990)

Analysis of soluble interleukin-2 receptor as CSF biomarker for neurosarcoidosis
por: Otto, Carolin, et al.
Publicado: (2020)

Performance of serum soluble interleukin-2 receptor as a diagnostic marker for lymphoma in patients with fever
por: Kanda, Naoki, et al.
Publicado: (2023)

The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab
por: Shima, Yoshihito, et al.
Publicado: (2010)

Interleukin-6 Receptor Polymorphism Is Prevalent in HIV-negative Castleman Disease and Is Associated with Increased Soluble Interleukin-6 Receptor Levels
por: Stone, Katie, et al.
Publicado: (2013)

Interleukin‐6 receptor alpha blockade improves skin lesions in a murine model of systemic lupus erythematosus
por: Birner, Peter, et al.
Publicado: (2016)

Serum soluble interleukin-2 receptor level is a predictive marker for EBUS-TBNA-based diagnosis of sarcoidosis
por: Miyata, Jun, et al.
Publicado: (2020)

A model of the ternary complex of interleukin-10 with its soluble receptors
por: Pletnev, Sergei, et al.
Publicado: (2005)

Proinflammatory Soluble Interleukin-15 Receptor Alpha Is Increased in Rheumatoid Arthritis
por: Machado Diaz, Ana Cecilia, et al.
Publicado: (2012)

Soluble interleukin-6 receptor in the COVID-19 cytokine storm syndrome
por: Chen, Luke Y.C., et al.
Publicado: (2021)

Rapidly Progressed Primary Intestinal Follicular Lymphoma with Elevation of Soluble Interleukin-2 Receptor Levels
por: Iwamuro, Masaya, et al.
Publicado: (2014)

Interleukin-5 and IL-5 receptor in health and diseases
por: TAKATSU, Kiyoshi
Publicado: (2011)

Serum levels of interleukin-6 type cytokines and soluble interleukin-6 receptor in patients with rheumatoid arthritis.
por: Robak, T, et al.
Publicado: (1998)

Soluble interleukin-2 receptor α and interleukin-2 serum levels in patients with basal cell carcinoma
por: Sobjanek, Michal, et al.
Publicado: (2016)

Generation of Soluble Interleukin-11 and Interleukin-6 Receptors: A Crucial Function for Proteases during Inflammation
por: Lokau, Juliane, et al.
Publicado: (2016)

Soluble Interleukin-6 Receptor Regulates Interleukin-6-Dependent Vascular Remodeling in Long-Distance Runners
por: Villar-Fincheira, Paulina, et al.
Publicado: (2021)

Induction of soluble tumour necrosis factor receptors during treatment with interleukin-2.
por: Miles, D. W., et al.
Publicado: (1992)

Increased levels of soluble interleukin-2 receptors in serum of patients with lung cancer.
por: Marino, P., et al.
Publicado: (1990)

Increased levels of soluble interleukin-6 receptor and CCL3 in COPD sputum
por: Ravi, Arjun K, et al.
Publicado: (2014)

Relationship of Soluble Interleukin-6 Receptors With Asthma: A Mendelian Randomization Study
por: Raita, Yoshihiko, et al.
Publicado: (2021)

Soluble interleukin 2 receptor is risk for sarcopenia in Men with high fracture risk
por: Ge, Jiaying, et al.
Publicado: (2022)

Detection of soluble interleukin-2 receptor and soluble intercellular adhesion molecule-1 in the effusion of otitis media with effusion
por: Ganbo, T., et al.
Publicado: (1995)

Soluble interleukin-2 receptor, intercellular adhesion molecule-1 and interleukin-10 serum levels in patients withelanoma
por: Boyano, M D, et al.
Publicado: (2000)

Hyperinsulinemia is Associated with Increased Soluble Insulin Receptors Release from Hepatocytes
por: Hiriart, Marcia, et al.
Publicado: (2014)

Preeclampsia Status Controls Interleukin-6 and Soluble IL-6 Receptor Release from Neutrophils and Endothelial Cells: Relevance to Increased Inflammatory Responses
por: Wang, Yuping, et al.
Publicado: (2021)

Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI): significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibition therapy
por: Nishimoto, Norihiro, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_4ug1lkro6b8642stp6k5d3ug4b